These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19383947)

  • 1. Off-label cancer drug compendia found outdated and incomplete.
    Mitka M
    JAMA; 2009 Apr; 301(16):1645-6. PubMed ID: 19383947
    [No Abstract]   [Full Text] [Related]  

  • 2. Systematic review: reliability of compendia methods for off-label oncology indications.
    Abernethy AP; Raman G; Balk EM; Hammond JM; Orlando LA; Wheeler JL; Lau J; McCrory DC
    Ann Intern Med; 2009 Mar; 150(5):336-43. PubMed ID: 19221366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating off-label uses of anticancer drugs: time for a change.
    Sox HC
    Ann Intern Med; 2009 Mar; 150(5):353-4. PubMed ID: 19221369
    [No Abstract]   [Full Text] [Related]  

  • 4. Compendia and anticancer therapy under Medicare.
    Tillman K; Burton B; Jacques LB; Phurrough SE
    Ann Intern Med; 2009 Mar; 150(5):348-50. PubMed ID: 19221368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlling off-label medication use.
    Gillick MR
    Ann Intern Med; 2009 Mar; 150(5):344-7. PubMed ID: 19221367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inadequacies of statutory drug compendia also affect the mental health field.
    Paczynski RP; Kruszewski SP
    Ann Intern Med; 2009 Sep; 151(5):364-5. PubMed ID: 19721028
    [No Abstract]   [Full Text] [Related]  

  • 7. Quality of evidence in drug compendia supporting off-label use of typical and atypical antipsychotic medications.
    Paczynski RP; Alexander GC; Chinchilli VM; Kruszewski SP
    Int J Risk Saf Med; 2012 Jan; 24(3):137-46. PubMed ID: 22936056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineoplastic agents: comparing off-label uses among authoritative drug compendia.
    Thompson DF; Keefe CC
    Hosp Formul; 1993 Jul; 28(7):641-2, 647. PubMed ID: 10127046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outdated Prescription Drug Labeling: How FDA-Approved Prescribing Information Lags Behind Real-World Clinical Practice.
    Shea MB; Stewart M; Van Dyke H; Ostermann L; Allen J; Sigal E
    Ther Innov Regul Sci; 2018 Nov; 52(6):771-777. PubMed ID: 29714570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reimbursement for cancer treatment: coverage of off-label drug indications.
    American Society of Clinical Oncology
    J Clin Oncol; 2006 Jul; 24(19):3206-8. PubMed ID: 16717290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bias at the gate?: The pharmaceutical industry's influence on the federally approved drug compendia.
    Gabrielsen L
    Am J Law Med; 2014; 40(1):141-63. PubMed ID: 24844045
    [No Abstract]   [Full Text] [Related]  

  • 12. Off-label use of anti-cancer drugs in India: to be or not to be!
    Gota V; Patial P
    J Cancer Res Ther; 2011; 7(1):35-9. PubMed ID: 21546740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Off-label uses of trastuzumab.
    Tecnologica MAP Suppl; 1999 Apr; ():22-3. PubMed ID: 10848167
    [No Abstract]   [Full Text] [Related]  

  • 14. The diminishing value of the Physicians' Desk Reference and drug package inserts as a medical and legal standard of medical usage of pharmaceutical drugs.
    Burkhart CG
    J Drugs Dermatol; 2005; 4(4):414-5. PubMed ID: 16004013
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experience.
    Kocs D; Fendrick AM
    Am J Manag Care; 2003 May; 9(5):393-400; quiz 401-2. PubMed ID: 12744301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reflections about off-label use of anticancer drugs.
    Tartarone A; Lerose R; Aieta M
    Ther Drug Monit; 2012 Oct; 34(5):604. PubMed ID: 22972541
    [No Abstract]   [Full Text] [Related]  

  • 17. [Off-label therapies in oncology].
    Telekes A
    Orv Hetil; 2009 Feb; 150(8):363-72. PubMed ID: 19218146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug compendia in oncology: are they flawed?
    Twombly R
    J Natl Cancer Inst; 2009 Dec; 101(23):1604-6. PubMed ID: 19910556
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of off-label drugs in cancer care again under review.
    Braud E; Downs CG
    ONS News; 2005 Mar; 20(3):8. PubMed ID: 15794064
    [No Abstract]   [Full Text] [Related]  

  • 20. Diabetes.
    Stud Anc Med; 2009; 38():283-323. PubMed ID: 20481151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.